Full text
PDFPage 5433

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caplen H., Peters C. J., Bishop D. H. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol. 1985 Oct;66(Pt 10):2271–2277. doi: 10.1099/0022-1317-66-10-2271. [DOI] [PubMed] [Google Scholar]
- Giorgi C., Accardi L., Nicoletti L., Gro M. C., Takehara K., Hilditch C., Morikawa S., Bishop D. H. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology. 1991 Feb;180(2):738–753. doi: 10.1016/0042-6822(91)90087-r. [DOI] [PubMed] [Google Scholar]
- Saluzzo J. F., Smith J. F. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine. 1990 Aug;8(4):369–375. doi: 10.1016/0264-410x(90)90096-5. [DOI] [PubMed] [Google Scholar]
- Takehara K., Min M. K., Battles J. K., Sugiyama K., Emery V. C., Dalrymple J. M., Bishop D. H. Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus. Virology. 1989 Apr;169(2):452–457. doi: 10.1016/0042-6822(89)90171-2. [DOI] [PubMed] [Google Scholar]
